Search Results
Imsidolimab for the treatment of generalized pustular psoriasis, R.B. Warren et al.
Clinical Characteristics and Course of GPP | Siew Eng Choon, MBBS, FRCP | Malaysia
Pustular Psoriasis Treatment Review
Results of phase III trial of lebrikizumab in moderate-to-severe AD at 52 weeks, A. Blauvelt et al.